Base excision repair and cancer

Cancer Letters

Volumn 327, Issue 1-2, 2012, Pages 73-89

  Wallace, Susan S ^a   Murphy, Drew L ^b   Sweasy, Joann B ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Base excision repair; Cancer variants

Indexed keywords

8 HYDROXYGUANINE; APURINIC ENDONUCLEASE 1; APURINIC ENDONUCLEASE 2; DNA DIRECTED DNA POLYMERASE BETA; DNA GLYCOSYLTRANSFERASE; ENDONUCLEASE; LIGASE III ALPHA; LITHOCHOLIC ACID; METHYL CPG BINDING DOMAIN PROTEIN 4; METHYLPURINE DNA GLYCOSYLASE; OXIDIZED PYRIMIDINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN NEIL1; PROTEIN NEIL2; PROTEIN NEIL3; PROTEIN NTH1; PROTEIN OGG1; PROTEIN SMUG1; PYRIMIDINE DERIVATIVE; TEMOZOLOMIDE; THYMINE DNA GLYCOSYLASE; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE; XRCC1 PROTEIN;

APEX 1 GENE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DISEASE ASSOCIATION; DISEASE MODEL; DNA BINDING; DNA POLYMORPHISM; DRUG MECHANISM; DRUG TARGETING; EXCISION REPAIR; GENE; GENE MUTATION; GENETIC VARIABILITY; GERM LINE; HUMAN; KNOCKOUT MOUSE; LIGASE III ALPHA GENE; METHYL CPG BINDING DOMAIN PROTEIN 4 GENE; MUTYH GENE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT PATCH BASE EXCISION REPAIR; SHORT SURVEY; SMUG GENE; TDG GENE; UNG GENE; XRCC1 GENE;

MAMMALIA;

EID: 84865093016     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.12.038     Document Type: Review

References (346)

1. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington, DC. second ed.
2. Lindahl T. An N-glycosidase from Escherichia coli that releases free uracil from DNA containing deaminated cytosine residues. Proc. Natl. Acad. Sci. USA 1974, 71:3649-3653.
3. Mitra S., Hazra T.K., Roy R., Ikeda S., Biswas T., Lock J., Boldogh I., Izumi T. Complexities of DNA base excision repair in mammalian cells. Mol. Cells 1997, 7:305-312.
4. Krokan H.E., Nilsen H., Skorpen F., Otterlei M., Slupphaug G. Base excision repair of DNA in mammalian cells. FEBS Lett. 2000, 476:73-77.
5. Mitra S., Izumi T., Boldogh I., Bhakat K.K., Hill J.W., Hazra T.K. Choreography of oxidative damage repair in mammalian genomes. Free Radic. Biol. Med. 2002, 33:15-28.
6. Izumi T., Wiederhold L.R., Roy G., Roy R., Jaiswal A., Bhakat K.K., Mitra S., Hazra T.K. Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 2003, 193:43-65.
7. Fromme J.C., Verdine G.L. Base excision repair. Adv. Protein Chem. 2004, 69:1-41.
8. Barnes D.E., Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 2004, 38:445-476.
9. Wallace S.S. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat. Res. 1998, 150:S60-79.
10. Gros L., Saparbaev M.K., Laval J. Enzymology of the repair of free radicals-induced DNA damage. Oncogene 2002, 21:8905-8925.
11. Zharkov D.O. Base excision DNA repair. Cell Mol. Life Sci. 2008, 65:1544-1565.
12. Doetsch P.W., Cunningham R.P. The enzymology of apurinic/apyrimidinic endonucleases. Mutat. Res. 1990, 236:173-201.
13. Matsumoto Y., Kim K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 1995, 269:699-702.
14. Prasad R., Beard W.A., Strauss P.R., Wilson S.H. Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. J. Biol. Chem. 1998, 273:15263-15270.
15. Bailly V., Verly W.G. Escherichia coli endonuclease III is not an endonuclease but a beta-elimination catalyst. Biochem. J. 1987, 242:565-572.
16. Bailly V., Derydt M., Verly W.G. Delta-elimination in the repair of AP (apurinic/apyrimidinic) sites in DNA. Biochem. J. 1989, 261:707-713.
17. Chen D.S., Herman T., Demple B. Two distinct human DNA diesterases that hydrolyze 3'-blocking deoxyribose fragments from oxidized DNA. Nucleic Acids Res. 1991, 19:5907-5914.
18. Wiederhold L., Leppard J.B., Kedar P., Karimi-Busheri F., Rasouli-Nia A., Weinfeld M., Tomkinson A.E., Izumi T., Prasad R., Wilson S.H., Mitra S., Hazra T.K. AP endonuclease-independent DNA base excision repair in human cells. Mol. Cell 2004, 15:209-220.
19. Sobol R.W., Horton J.K., Kuhn R., Gu H., Singhal R.K., Prasad R., Rajewsky K., Wilson S.H. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature 1996, 379:183-186.
20. Prasad R., Shock D.D., Beard W.A., Wilson S.H. Substrate channeling in mammalian base excision repair pathways: passing the baton. J. Biol. Chem. 2010, 285:40479-40488.
21. Tomkinson A.E., Mackey Z.B. Structure and function of mammalian DNA ligases. Mutat. Res. 1998, 407:1-9.
22. Caldecott K.W. Single-strand break repair and genetic disease. Nat. Rev. Genet. 2008, 9:619-631.
23. Campalans A., Marsin S., Nakabeppu Y., O'Connor R., Boiteux T.S., Radicella J.P. XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair (Amst.) 2005, 4:826-835.
24. Caldecott K.W., Aoufouchi S., Johnson P., Shall S. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res. 1996, 24:4387-4394.
25. Caldecott K.W., McKeown C.K., Tucker J.D., Ljungquist S., Thompson L.H. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol. Cell Biol. 1994, 14:68-76.
26. Dianov G.L., Prasad R., Wilson S.H., Bohr V.A. Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair. J. Biol. Chem. 1999, 274:13741-13743.
27. Almeida K.H., Sobol R.W. A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst.) 2007, 6:695-711.
28. Sung J.S., DeMott M.S., Demple B. Long-patch base excision DNA repair of 2-deoxyribonolactone prevents the formation of DNA-protein cross-links with DNA polymerase beta. J. Biol. Chem. 2005, 280:39095-39103.
29. DeMott M.S., Beyret E., Wong D., Bales B.C., Hwang J.T., Greenberg M.M., Demple B. Covalent trapping of human DNA polymerase beta by the oxidative DNA lesion 2-deoxyribonolactone. J. Biol. Chem. 2002, 277:7637-7640.
30. Huggins C.F., Chafin D.R., Aoyagi S., Henricksen L.A., Bambara R.A., Hayes J.J. Flap endonuclease 1 efficiently cleaves base excision repair and DNA replication intermediates assembled into nucleosomes. Mol. Cell 2002, 10:1201-1211.
31. Balakrishnan L., Brandt P.D., Lindsey-Boltz L.A., Sancar A., Bambara R.A. Long patch base excision repair proceeds via coordinated stimulation of the multienzyme DNA repair complex. J. Biol. Chem. 2009, 284:15158-15172.
32. Prasad R., Dianov G.L., Bohr V.A., Wilson S.H. FEN1 stimulation of DNA polymerase beta mediates an excision step in mammalian long patch base excision repair. J. Biol. Chem. 2000, 275:4460-4466.
33. Petermann E., Keil C., Oei S.L. Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair (Amst.) 2006, 5:544-555.
34. Hegde M.L., Hazra T.K., Mitra S. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Res. 2008, 18:27-47.
35. Frosina G. Commentary: DNA base excision repair defects in human pathologies. Free Radic Res. 2004, 38:1037-1054.
36. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162:925-942.
37. Nohmi T., Kim S.R., Yamada M. Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat. Res. 2005, 591:60-73.
38. Chan K.K., Zhang Q.M., Dianov G.L. Base excision repair fidelity in normal and cancer cells. Mutagenesis 2006, 21:173-178.
39. Sweasy J.B., Lang T., DiMaio D. Is base excision repair a tumor suppressor mechanism?. Cell Cycle 2006, 5:250-259.
40. Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol. Aspects Med. 2007, 28:258-275.
41. D'Errico M., Parlanti E., Dogliotti E. Mechanism of oxidative DNA damage repair and relevance to human pathology. Mutat. Res. 2008, 659:4-14.
42. Paz-Elizur T., Sevilya Z., Leitner-Dagan Y., Elinger D., Roisman L.C., Livneh Z. DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett. 2008, 266:60-72.
43. Nemec A.A., Wallace S.S., Sweasy J.B. Variant base excision repair proteins: contributors to genomic instability. Semin. Cancer Biol. 2010, 20:320-328.
44. Wilson D.M., Kim D., Berquist B.R., Sigurdson A.J. Variation in base excision repair capacity. Mutat. Res. 2011, 711:100-112.
45. Krokan H.E., Drablos F., Slupphaug G. Uracil in DNA - occurrence, consequences and repair. Oncogene 2002, 21:8935-8948.
46. Visnes T., Doseth B., Pettersen H.S., Hagen L., Sousa M.M., Akbari M., Otterlei M., Kavli B., Slupphaug G., Krokan H.E. Uracil in DNA and its processing by different DNA glycosylases. Philos. Trans. Roy. Soc. Lond., Ser. B: Biol. Sci. 2009, 364:563-568.
47. Otterlei M., Warbrick E., Nagelhus T.A., Haug T., Slupphaug G., Akbari M., Aas P.A., Steinsbekk K., Bakke O., Krokan H.E. Post-replicative base excision repair in replication foci. EMBO J. 1999, 18:3834-3844.
48. Nilsen H., Rosewell I., Robins P., Skjelbred C.F., Andersen S., Slupphaug G., Daly G., Krokan H.E., Lindahl T., Barnes D.E. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol. Cell 2000, 5:1059-1065.
49. Akbari M., Otterlei M., Pena-Diaz J., Aas P.A., Kavli B., Liabakk N.B., Hagen L., Imai K., Durandy A., Slupphaug G., Krokan H.E. Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells. Nucleic Acids Res. 2004, 32:5486-5498.
50. Kavli B., Sundheim O., Akbari M., Otterlei M., Nilsen H., Skorpen F., Aas P.A., Hagen L., Krokan H.E., Slupphaug G. hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J. Biol. Chem. 2002, 277:39926-39936.
51. Kavli B., Otterlei M., Slupphaug G., Krokan H.E. Uracil in DNA - general mutagen, but normal intermediate in acquired immunity. DNA Repair (Amst.) 2007, 6:505-516.
52. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A., Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003, 4:1023-1028.
53. Mol C.D., Arvai A.S., Slupphaug G., Kavli B., Alseth I., Krokan H.E., Tainer J.A. Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell 1995, 80:869-878.
54. Savva R., McAuley-Hecht K., Brown T., Pearl L. The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature 1995, 373:487-493.
55. Pearl L.H. Structure and function in the uracil-DNA glycosylase superfamily. Mutat. Res. 2000, 460:165-181.
56. Wibley J.E., Waters T.R., Haushalter K., Verdine G.L., Pearl L.H. Structure and specificity of the vertebrate anti-mutator uracil-DNA glycosylase SMUG1. Mol. Cell 2003, 11:1647-1659.
57. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999, 401:301-304.
58. Barrett T.E., Savva R., Panayotou G., Barlow T., Brown T., Jiricny J., Pearl L.H. Crystal structure of a G:T/U mismatch-specific DNA glycosylase: mismatch recognition by complementary-strand interactions. Cell 1998, 92:117-129.
59. Baba D., Maita N., Jee J.G., Uchimura Y., Saitoh H., Sugasawa K., Hanaoka F., Tochio H., Hiroaki H., Shirakawa M. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 2005, 435:979-982.
60. Maiti A., Morgan M.T., Pozharski E., Drohat A.C. Crystal structure of human thymine DNA glycosylase bound to DNA elucidates sequence-specific mismatch recognition. Proc. Natl. Acad. Sci. USA 2008, 105:8890-8895.
61. He Y.F., Li B.Z., Li Z., Liu P., Wang Y., Tang Q., Ding J., Jia Y., Chen Z., Li L., Sun Y., Li X., Dai Q., Song C.X., Zhang K., He C., Xu G.L. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
62. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
63. Mol C.D., Arvai A.S., Begley T.J., Cunningham R.P., Tainer J.A. Structure and activity of a thermostable thymine-DNA glycosylase: evidence for base twisting to remove mismatched normal DNA bases. J. Mol. Biol. 2002, 315:373-384.
64. Wakefield R.I., Smith B.O., Nan X., Free A., Soteriou A., Uhrin D., Bird A.P., Barlow P.N. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol. 1999, 291:1055-1065.
65. Ohki I., Shimotake N., Fujita N., Jee J., Ikegami T., Nakao M., Shirakawa M. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 2001, 105:487-497.
66. Zhu J.K. Active DNA demethylation mediated by DNA glycosylases. Annu. Rev. Genet. 2009, 43:143-166.
67. Friedberg E.C., Meira L.B. Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7. DNA Repair (Amst.) 2006, 5:189-209.
68. Larsen E., Meza T.J., Kleppa L., Klungland A. Organ and cell specificity of base excision repair mutants in mice. Mutat. Res. 2007, 614:56-68.
69. Nilsen H., Stamp G., Andersen S., Hrivnak G., Krokan H.E., Lindahl T., Barnes D.E. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 2003, 22:5381-5386.
70. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., Keightley P.D., Bishop S.M., Clarke A.R., Bird A. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 2002, 297:403-405.
71. Cortazar D., Kunz C., Selfridge J., Lettieri T., Saito Y., MacDougall E., Wirz A., Schuermann D., Jacobs A.L., Siegrist F., Steinacher R., Jiricny J., Bird A., Schar P. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 2011, 470:419-423.
72. Broderick P., Bagratuni T., Vijayakrishnan J., Lubbe S., Chandler I., Houlston R.S. Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition. BMC Cancer 2006, 6:243.
73. Moon Y.W., Park W.S., Vortmeyer A.O., Weil R.J., Lee Y.S., Winters T.A., Zhuang Z., Fuller B.G. Mutation of the uracil DNA glycosylase gene detected in glioblastoma. Mutat. Res. 1998, 421:191-196.
74. Kvaloy K., Nilsen H., Steinsbekk K.S., Nedal A., Monterotti B., Akbari M., Krokan H.E. Sequence variation in the human uracil-DNA glycosylase (UNG) gene. Mutat. Res. 2001, 461:325-338.
75. Schmutte C., Baffa R., Veronese L.M., Murakumo Y., Fishel R. Human thymine-DNA glycosylase maps at chromosome 12q22-q24.1: a region of high loss of heterozygosity in gastric cancer. Cancer Res. 1997, 57:3010-3015.
76. Marian C., Tao M., Mason J.B., Goerlitz D.S., Nie J., Chanson A., Freudenheim J.L., Shields P.G. Single nucleotide polymorphisms in uracil-processing genes, intake of one-carbon nutrients and breast cancer risk. Eur. J. Clin. Nutr. 2011, 65:683-689.
77. Chanson A., Parnell L.D., Ciappio E.D., Liu Z., Crott J.W., Tucker K.L., Mason J.B. Polymorphisms in uracil-processing genes, but not one-carbon nutrients, are associated with altered DNA uracil concentrations in an urban Puerto Rican population. Am. J. Clin. Nutr. 2009, 89:1927-1936.
78. Krzesniak M., Butkiewicz D., Samojedny A., Chorazy M., Rusin M. Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland. Ann. Hum. Genet. 2004, 68:300-312.
79. Yamada T., Koyama T., Ohwada S., Tago K., Sakamoto I., Yoshimura S., Hamada K., Takeyoshi I., Morishita Y. Frameshift mutations in the MBD4/MED1 gene in primary gastric cancer with high-frequency microsatellite instability. Cancer Lett. 2002, 181:115-120.
80. Hao B., Wang H., Zhou K., Li Y., Chen X., Zhou G., Zhu Y., Miao X., Tan W., Wei Q., Lin D., He F. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004, 64:4378-4384.
81. Miao R., Gu H., Liu H., Hu Z., Jin G., Wang H., Wang Y., Sun W., Ma H., Chen D., Tian T., Jin L., Wei Q., Lu D., Huang W., Shen H. Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population. Lung Cancer 2008, 62:281-286.
82. Song J.H., Maeng E.J., Cao Z., Kim S.Y., Nam S.W., Lee J.Y., Park W.S. The Glu346Lys polymorphism and frameshift mutations of the Methyl-CpG Binding Domain 4 gene in gastrointestinal cancer. Neoplasma 2009, 56:343-347.
83. Chow E., Lipton L., Lynch E., D'Souza R., Aragona C., Hodgkin L., Brown G., Winship I., Barker M., Buchanan D., Cowie S., Nasioulas S., du Sart D., Young J., Leggett B., Jass J., Macrae F. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006, 131:30-39.
84. Dong J., Hu Z., Shu Y., Pan S., Chen W., Wang Y., Hu L., Jiang Y., Dai J., Ma H., Jin G., Shen H. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis. Mol. Carcinog. 2011.
85. Lindahl T. New class of enzymes acting on damaged DNA. Nature 1976, 259:64-66.
86. O'Connor T.R., Laval F. Isolation and structure of a cDNA expressing a mammalian 3-methyladenine-DNA glycosylase. EMBO J. 1990, 9:3337-3342.
87. Chakravarti D., Ibeanu G.C., Tano K., Mitra S. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase. J. Biol. Chem. 1991, 266:15710-15715.
88. O'Connor T.R., Laval J. Human cDNA expressing a functional DNA glycosylase excising 3-methyladenine and 7-methylguanine. Biochem. Biophys. Res. Commun. 1991, 176:1170-1177.
89. Samson L., Derfler B., Boosalis M., Call K. Cloning and characterization of a 3-methyladenine DNA glycosylase cDNA from human cells whose gene maps to chromosome 16. Proc. Natl. Acad. Sci. USA 1991, 88:9127-9131.
90. Dosanjh M.K., Chenna A., Kim E., Fraenkel-Conrat H., Samson L., Singer B. All four known cyclic adducts formed in DNA by the vinyl chloride metabolite chloroacetaldehyde are released by a human DNA glycosylase. Proc. Natl. Acad. Sci. USA 1994, 91:1024-1028.
91. Saparbaev M., Kleibl K., Laval J. Escherichia coli, Saccharomyces cerevisiae, rat and human 3-methyladenine DNA glycosylases repair 1,N6-ethenoadenine when present in DNA. Nucleic Acids Res. 1995, 23:3750-3755.
92. Saparbaev M., Laval J. Excision of hypoxanthine from DNA containing dIMP residues by the Escherichia coli, yeast, rat, and human alkylpurine DNA glycosylases. Proc. Natl. Acad. Sci. USA 1994, 91:5873-5877.
93. Bessho T., Roy R., Yamamoto K., Kasai H., Nishimura S., Tano K., Mitra S. Repair of 8-hydroxyguanine in DNA by mammalian N-methylpurine-DNA glycosylase. Proc. Natl. Acad. Sci. USA 1993, 90:8901-8904.
94. Lee C.Y., Delaney J.C., Kartalou M., Lingaraju G.M., Maor-Shoshani A., Essigmann J.M., Samson L.D. Recognition and processing of a new repertoire of DNA substrates by human 3-methyladenine DNA glycosylase (AAG). Biochemistry 2009, 48:1850-1861.
95. Lau A.Y., Scharer O.D., Samson L., Verdine G.L., Ellenberger T. Crystal structure of a human alkylbase-DNA repair enzyme complexed to DNA: mechanisms for nucleotide flipping and base excision. Cell 1998, 95:249-258.
96. Engelward B.P., Weeda G., Wyatt M.D., Broekhof J.L., de Wit J., Donker I., Allan J.M., Gold B., Hoeijmakers J.H., Samson L.D. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA 1997, 94:13087-13092.
97. Elder R.H., Jansen J.G., Weeks R.J., Willington M.A., Deans B., Watson A.J., Mynett K.J., Bailey J.A., Cooper D.P., Rafferty J.A., Heeran M.C., Wijnhoven S.W., van Zeeland A.A., Margison G.P. Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol. Cell Biol. 1998, 18:5828-5837.
98. Wirtz S., Nagel G., Eshkind L., Neurath M.F., Samson L.D., Kaina B. Both base excision repair and O6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesis. Carcinogenesis 2010, 31:2111-2117.
99. Meira L.B., Bugni J.M., Green S.L., Lee C.W., Pang B., Borenshtein D., Rickman B.H., Rogers A.B., Moroski-Erkul C.A., McFaline J.L., Schauer D.B., Dedon P.C., Fox J.G., Samson L.D. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 2008, 118:2516-2525.
100. Engelward B.P., Dreslin A., Christensen J., Huszar D., Kurahara C., Samson L. Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J. 1996, 15:945-952.
101. Roth R.B., Samson L.D. 3-Methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance. Cancer Res. 2002, 62:656-660.
102. Coquerelle T., Dosch J., Kaina B. Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents - a case of imbalanced DNA repair. Mutat. Res. 1995, 336:9-17.
103. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., Phillips D.H., Canzian F., Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27:560-567.
104. Haiman C.A., Garcia R.R., Hsu C., Xia L., Ha H., Sheng X., Le Marchand L., Kolonel L.N., Henderson B.E., Stallcup M.R., Greene G.L., Press M.F. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort. BMC Cancer 2009, 9:43.
105. Rusin M., Samojedny A., Harris C.C., Chorazy M. Novel genetic polymorphisms in DNA repair genes: O(6)-methylguanine-DNA methyltransferase (MGMT) and N-methylpurine-DNA glycosylase (MPG) in lung cancer patients from Poland. Hum. Mutat. 1999, 14:269-270.
106. Mirabello L., Yu K., Berndt S.I., Burdett L., Wang Z., Chowdhury S., Teshome K., Uzoka A., Hutchinson A., Grotmol T., Douglass C., Hayes R.B., Hoover R.N., Savage S.A. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 2011, 11:209.
107. Lu R., Nash H.M., Verdine G.L. A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer. Curr. Biol. 1997, 7:397-407.
108. Arai K., Morishita K., Shinmura K., Kohno T., Kim S.R., Nohmi T., Taniwaki M., Ohwada S., Yokota J. Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene 1997, 14:2857-2861.
109. Aburatani H., Hippo Y., Ishida T., Takashima R., Matsuba C., Kodama T., Takao M., Yasui A., Yamamoto K., Asano M. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res. 1997, 57:2151-2156.
110. Radicella J.P., Dherin C., Desmaze C., Fox M.S., Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1997, 94:8010-8015.
111. Roldan-Arjona T., Wei Y.F., Carter K.C., Klungland A., Anselmino C., Wang R.P., Augustus M., Lindahl T. Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase. Proc. Natl. Acad. Sci. USA 1997, 94:8016-8020.
112. Bjoras M., Luna L., Johnsen B., Hoff E., Haug T., Rognes T., Seeberg E. Opposite base-dependent reactions of a human base excision repair enzyme on DNA containing 7,8-dihydro-8-oxoguanine and abasic sites. EMBO J. 1997, 16:6314-6322.
113. Girard P.M., D'Ham C., Cadet J., Boiteux S. Opposite base-dependent excision of 7,8-dihydro-8-oxoadenine by the Ogg1 protein of Saccharomyces cerevisiae. Carcinogenesis 1998, 19:1299-1305.
114. Zharkov D.O., Rosenquist T.A., Gerchman S.E., Grollman A.P. Substrate specificity and reaction mechanism of murine 8-oxoguanine-DNA glycosylase. J. Biol. Chem. 2000, 275:28607-28617.
115. Asagoshi K., Yamada T., Okada Y., Terato H., Ohyama Y., Seki S., Ide H. Recognition of formamidopyrimidine by Escherichia coli and mammalian thymine glycol glycosylases. Distinctive paired base effects and biological and mechanistic implications. J. Biol. Chem. 2000, 275:24781-24786.
116. Asagoshi K., Yamada T., Terato H., Ohyama Y., Monden Y., Arai T., Nishimura S., Aburatani H., Lindahl T., Ide H. Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine. J. Biol. Chem. 2000, 275:4956-4964.
117. Bruner S.D., Norman D.P., Verdine G.L. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000, 403:859-866.
118. Bjoras M., Seeberg E., Luna L., Pearl L.H., Barrett T.E. Reciprocal "flipping" underlies substrate recognition and catalytic activation by the human 8-oxo-guanine DNA glycosylase. J. Mol. Biol. 2002, 317:171-177.
119. Brieba L.G., Eichman B.F., Kokoska R.J., Doublie S., Kunkel T.A., Ellenberger T. Structural basis for the dual coding potential of 8-oxoguanosine by a high-fidelity DNA polymerase. EMBO J. 2004, 23:3452-3461.
120. Hsu G.W., Ober M., Carell T., Beese L.S. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature 2004, 431:217-221.
121. Au K.G., Cabrera M., Miller J.H., Modrich P. Escherichia coli mutY gene product is required for specific A-G--C.G mismatch correction. Proc. Natl. Acad. Sci. USA 1988, 85:9163-9166.
122. McGoldrick J.P., Yeh Y.C., Solomon M., Essigmann J.M., Lu A.L. Characterization of a mammalian homolog of the Escherichia coli MutY mismatch repair protein. Mol. Cell Biol. 1995, 15:989-996.
123. Lu A.L., Tsai-Wu J.J., Cillo J. DNA determinants and substrate specificities of Escherichia coli MutY. J. Biol. Chem. 1995, 270:23582-23588.
124. Slupska M.M., Baikalov C., Luther W.M., Chiang J.H., Wei Y.F., Miller J.H. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J. Bacteriol. 1996, 178:3885-3892.
125. Slupska M.M., Luther W.M., Chiang J.H., Yang H., Miller J.H. Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein. J. Bacteriol. 1999, 181:6210-6213.
126. Wiederholt C.J., Delaney M.O., Pope M.A., David S.S., Greenberg M.M. Repair of DNA containing Fapy.dG and its beta-C-nucleoside analogue by formamidopyrimidine DNA glycosylase and MutY. Biochemistry 2003, 42:9755-9760.
127. Pope M.A., David S.S. DNA damage recognition and repair by the murine MutY homologue. DNA Repair (Amst.) 2005, 4:91-102.
128. Guan Y., Manuel R.C., Arvai A.S., Parikh S.S., Mol C.D., Miller J.H., Lloyd S., Tainer J.A. MutY catalytic core, mutant and bound adenine structures define specificity for DNA repair enzyme superfamily. Nat. Struct. Biol. 1998, 5:1058-1064.
129. Fromme J.C., Banerjee A., Huang S.J., Verdine G.L. Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase. Nature 2004, 427:652-656.
130. Michaels M.L., Pham L., Nghiem Y., Cruz C., Miller J.H. MutY, an adenine glycosylase active on G-A mispairs, has homology to endonuclease III. Nucleic Acids Res. 1990, 18:3841-3845.
131. Cunningham R.P. DNA glycosylases. Mutat. Res. 1997, 383:189-196.
132. Mazurek A., Berardini M., Fishel R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J. Biol. Chem. 2002, 277:8260-8266.
133. Colussi C., Parlanti E., Degan P., Aquilina G., Barnes D., Macpherson P., Karran P., Crescenzi M., Dogliotti E., Bignami M. The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr. Biol. 2002, 12:912-918.
134. Macpherson P., Barone F., Maga G., Mazzei F., Karran P., Bignami M. 8-Oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSalpha. Nucleic Acids Res. 2005, 33:5094-5105.
135. Klungland A., Rosewell I., Hollenbach S., Larsen E., Daly G., Epe B., Seeberg E., Lindahl T., Barnes D.E. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA 1999, 96:13300-13305.
136. Minowa O., Arai T., Hirano M., Monden Y., Nakai S., Fukuda M., Itoh M., Takano H., Hippou Y., Aburatani H., Masumura K., Nohmi T., Nishimura S., Noda T. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc. Natl. Acad. Sci. USA 2000, 97:4156-4161.
137. Osterod M., Hollenbach S., Hengstler J.G., Barnes D.E., Lindahl T., Epe B. Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice. Carcinogenesis 2001, 22:1459-1463.
138. Arai T., Kelly V.P., Minowa O., Noda T., Nishimura S. High accumulation of oxidative DNA damage, 8-hydroxyguanine, in Mmh/Ogg1 deficient mice by chronic oxidative stress. Carcinogenesis 2002, 23:2005-2010.
139. Kunisada M., Sakumi K., Tominaga Y., Budiyanto A., Ueda M., Ichihashi M., Nakabeppu Y., Nishigori C. 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis. Cancer Res. 2005, 65:6006-6010.
140. Xie Y., Yang H., Cunanan C., Okamoto K., Shibata D., Pan J., Barnes D.E., Lindahl T., McIlhatton M., Fishel R., Miller J.H. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res. 2004, 64:3096-3102.
141. Hirano S., Tominaga Y., Ichinoe A., Ushijima Y., Tsuchimoto D., Honda-Ohnishi Y., Ohtsubo T., Sakumi K., Nakabeppu Y. Mutator phenotype of MUTYH-null mouse embryonic stem cells. J. Biol. Chem. 2003, 278:38121-38124.
142. Russo M.T., De Luca G., Degan P., Parlanti E., Dogliotti E., Barnes D.E., Lindahl T., Yang H., Miller J.H., Bignami M. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res. 2004, 64:4411-4414.
143. Weiss J.M., Goode E.L., Ladiges W.C., Ulrich C.M. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog. 2005, 42:127-141.
144. Li H., Hao X., Zhang W., Wei Q., Chen K. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1739-1745.
145. Chang C.H., Hsiao C.F., Chang G.C., Tsai Y.H., Chen Y.M., Huang M.S., Su W.C., Hsieh W.S., Yang P.C., Chen C.J., Hsiung C.A. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Am. J. Epidemiol. 2009, 170:695-702.
146. Pawlowska E., Janik-Papis K., Rydzanicz M., Zuk K., Kaczmarczyk D., Olszewski J., Szyfter K., Blasiak J., Morawiec-Sztandera A. The Cys326 allele of the 8-oxoguanine DNA N-glycosylase 1 gene as a risk factor in smoking- and drinking-associated larynx cancer. Tohoku J. Exp. Med. 2009, 219:269-275.
147. Gu D., Wang M., Zhang Z., Chen J. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. Breast Cancer Res. Treat. 2010, 122:527-531.
148. Curtin K., Samowitz W.S., Wolff R.K., Ulrich C.M., Caan B.J., Potter J.D., Slattery M.L. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol. Biomarkers Prev. 2009, 18:3384-3388.
149. Liu C.J., Hsia T.C., Tsai R.Y., Sun S.S., Wang C.H., Lin C.C., Tsai C.W., Huang C.Y., Hsu C.M., Bau D.T. The joint effect of hOGG1 single nucleotide polymorphism and smoking habit on lung cancer in Taiwan. Anticancer Res. 2010, 30:4141-4145.
150. Stanczyk M., Sliwinski T., Cuchra M., Zubowska M., Bielecka-Kowalska A., Kowalski M., Szemraj J., Mlynarski W., Majsterek I. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol. Biol. Rep. 2011, 38:445-451.
151. Zhao H., Qin C., Yan F., Wu B., Cao Q., Wang M., Zhang Z., Yin C. hOGG1 Ser326Cys polymorphism and renal cell carcinoma risk in a Chinese population. DNA Cell Biol. 2011, 30:317-321.
152. Chen X., Wang J., Guo W., Liu X., Sun C., Cai Z., Fan Y., Wang Y. Two functional variations in 5'-UTR of hoGG1 gene associated with the risk of breast cancer in Chinese. Breast Cancer Res. Treat. 2011, 127:795-803.
153. Audebert M., Radicella J.P., Dizdaroglu M. Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the Ogg1 protein. Nucleic Acids Res. 2000, 28:2672-2678.
154. Dherin C., Radicella J.P., Dizdaroglu M., Boiteux S. Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res. 1999, 27:4001-4007.
155. Sidorenko V.S., Grollman A.P., Jaruga P., Dizdaroglu M., Zharkov D.O. Substrate specificity and excision kinetics of natural polymorphic variants and phosphomimetic mutants of human 8-oxoguanine-DNA glycosylase. FEBS J. 2009, 276:5149-5162.
156. Janssen K., Schlink K., Gotte W., Hippler B., Kaina B., Oesch F. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat. Res. 2001, 486:207-216.
157. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Sugimura H., Nohmi T., Kasai H., Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
158. Yamane A., Kohno T., Ito K., Sunaga N., Aoki K., Yoshimura K., Murakami H., Nojima Y., Yokota J. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 2004, 25:1689-1694.
159. Hill J.W., Evans M.K. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res. 2006, 34:1620-1632.
160. Smart D.J., Chipman J.K., Hodges N.J. Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2'-deoxyguanosine. DNA Repair (Amst.) 2006, 5:1337-1345.
161. Bravard A., Vacher M., Moritz E., Vaslin L., Hall J., Epe B., Radicella J.P. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res. 2009, 69:3642-3649.
162. Luna L., Rolseth V., Hildrestrand G.A., Otterlei M., Dantzer F., Bjoras M., Seeberg E. Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harbouring the hOGG1-Cys326 polymorphic variant. Nucleic Acids Res. 2005, 33:1813-1824.
163. Dallosso A.R., Dolwani S., Jones N., Jones S., Colley J., Maynard J., Idziaszczyk S., Humphreys V., Arnold J., Donaldson A., Eccles D., Ellis A., Evans D.G., Frayling I.M., Hes F.J., Houlston R.S., Maher E.R., Nielsen M., Parry S., Tyler E., Moskvina V., Cheadle J.P., Sampson J.R. Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3. Gut 2008, 57:1252-1255.
164. Forsbring M., Vik E.S., Dalhus B., Karlsen T.H., Bergquist A., Schrumpf E., Bjoras M., Boberg K.M., Alseth I. Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma. Carcinogenesis 2009, 30:1147-1154.
165. Chevillard S., Radicella J.P., Levalois C., Lebeau J., Poupon M.F., Oudard S., Dutrillaux B., Boiteux S. Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 1998, 16:3083-3086.
166. Audebert M., Chevillard S., Levalois C., Gyapay G., Vieillefond A., Klijanienko J., Vielh P., El Naggar A.K., Oudard S., Boiteux S., Radicella J.P. Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res. 2000, 60:4740-4744.
167. Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R., Cheadle J.P. Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat. Genet. 2002, 30:227-232.
168. Cheadle J.P., Sampson J.R. MUTYH-associated polyposis - from defect in base excision repair to clinical genetic testing. DNA Repair (Amst.) 2007, 6:274-279.
169. David S.S., O'Shea V.L., Kundu S. Base-excision repair of oxidative DNA damage. Nature 2007, 447:941-950.
170. Jasperson K.W., Tuohy T.M., Neklason D.W., Burt R.W. Hereditary and familial colon cancer. Gastroenterology 2010, 138:2044-2058.
171. Cheadle J.P., Sampson J.R. Exposing the MYtH about base excision repair and human inherited disease. Hum. Mol. Genet. 12 Spec. No. 2003, 2:R159-R165.
172. Jones S., Emmerson P., Maynard J., Best J.M., Jordan S., Williams G.T., Sampson J.R., Cheadle J.P. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C->T:A mutations. Hum. Mol. Genet. 2002, 11:2961-2967.
173. Boparai K.S., Dekker E., Van Eeden S., Polak M.M., Bartelsman J.F., Mathus-Vliegen E.M., Keller J.J., van Noesel C.J. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008, 135:2014-2018.
174. Vogt S., Jones N., Christian D., Engel C., Nielsen M., Kaufmann A., Steinke V., Vasen H.F., Propping P., Sampson J.R., Hes F.J., Aretz S. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 2009, 137:1976-1985. e1971-e1910.
175. Banerjee A., Santos W.L., Verdine G.L. Structure of a DNA glycosylase searching for lesions. Science 2006, 311:1153-1157.
176. Dunn A.R., Kad N.M., Nelson S.R., Warshaw D.M., Wallace S.S. Single Qdot-labeled glycosylase molecules use a wedge amino acid to probe for lesions while scanning along DNA. Nucleic Acids Res. 2011, 39:7487-7498.
177. Chmiel N.H., Livingston A.L., David S.S. Insight into the functional consequences of inherited variants of the hMYH adenine glycosylase associated with colorectal cancer: complementation assays with hMYH variants and pre-steady-state kinetics of the corresponding mutated E. coli enzymes. J. Mol. Biol. 2003, 327:431-443.
178. Alhopuro P., Parker A.R., Lehtonen R., Enholm S., Jarvinen H.J., Mecklin J.P., Karhu A., Eshleman J.R., Aaltonen L.A. A novel functionally deficient MYH variant in individuals with colorectal adenomatous polyposis. Hum. Mutat. 2005, 26:393.
179. Bai H., Jones S., Guan X., Wilson T.M., Sampson J.R., Cheadle J.P., Lu A.L. Functional characterization of two human MutY homolog (hMYH) missense mutations (R227W and V232F) that lie within the putative hMSH6 binding domain and are associated with hMYH polyposis. Nucleic Acids Res. 2005, 33:597-604.
180. Bai H., Grist S., Gardner J., Suthers G., Wilson T.M., Lu A.L. Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis. Cancer Lett. 2007, 250:74-81.
181. Ali M., Kim H., Cleary S., Cupples C., Gallinger S., Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology 2008, 135:499-507.
182. Kundu S., Brinkmeyer M.K., Livingston A.L., David S.S. Adenine removal activity and bacterial complementation with the human MutY homologue (MUTYH) and Y165C, G382D, P391L and Q324R variants associated with colorectal cancer. DNA Repair (Amst.) 2009, 8:1400-1410.
183. D'Agostino V.G., Minoprio A., Torreri P., Marinoni I., Bossa C., Petrucci T.C., Albertini A.M., Ranzani G.N., Bignami M., Mazzei F. Functional analysis of MUTYH mutated proteins associated with familial adenomatous polyposis. DNA Repair (Amst.) 2010, 9:700-707.
184. Goto M., Shinmura K., Nakabeppu Y., Tao H., Yamada H., Tsuneyoshi T., Sugimura H. Adenine DNA glycosylase activity of 14 human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancer. Hum. Mutat. 2010, 31:E1861-1874.
185. Molatore S., Russo M.T., D'Agostino V.G., Barone F., Matsumoto Y., Albertini A.M., Minoprio A., Degan P., Mazzei F., Bignami M., Ranzani G.N. MUTYH mutations associated with familial adenomatous polyposis: functional characterization by a mammalian cell-based assay. Hum. Mutat. 2010, 31:159-166.
186. Maki H., Sekiguchi M. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature 1992, 355:273-275.
187. Sakumi K., Furuichi M., Tsuzuki T., Kakuma T., Kawabata S., Maki H., Sekiguchi M. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J. Biol. Chem. 1993, 268:23524-23530.
188. Furuichi M., Yoshida M.C., Oda H., Tajiri T., Nakabeppu Y., Tsuzuki T., Sekiguchi M. Genomic structure and chromosome location of the human mutT homologue gene MTH1 encoding 8-oxo-dGTPase for prevention of A:T to C:G transversion. Genomics 1994, 24:485-490.
189. Noll D.M., Gogos A., Granek J.A., Clarke N.D. The C-terminal domain of the adenine-DNA glycosylase MutY confers specificity for 8-oxoguanine.adenine mispairs and may have evolved from MutT, an 8-oxo-dGTPase. Biochemistry 1999, 38:6374-6379.
190. Chmiel N.H., Golinelli M.P., Francis A.W., David S.S. Efficient recognition of substrates and substrate analogs by the adenine glycosylase MutY requires the C-terminal domain. Nucleic Acids Res. 2001, 29:553-564.
191. Nielsen M., Joerink-van de Beld M.C., Jones N., Vogt S., Tops C.M., Vasen H.F., Sampson J.R., Aretz S., Hes F.J. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology 2009, 136:471-476.
192. Croitoru M.E., Cleary S.P., Di Nicola N., Manno M., Selander T., Aronson M., Redston M., Cotterchio M., Knight J., Gryfe R., Gallinger S. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J. Natl. Cancer Inst. 2004, 96:1631-1634.
193. Jenkins M.A., Croitoru M.E., Monga N., Cleary S.P., Cotterchio M., Hopper J.L., Gallinger S. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol. Biomarkers Prev. 2006, 15:312-314.
194. Cleary S.P., Cotterchio M., Jenkins M.A., Kim H., Bristow R., Green R., Haile R., Hopper J.L., LeMarchand L., Lindor N., Parfrey P., Potter J., Younghusband B., Gallinger S. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2009, 136:1251-1260.
195. Jones N., Vogt S., Nielsen M., Christian D., Wark P.A., Eccles D., Edwards E., Evans D.G., Maher E.R., Vasen H.F., Hes F.J., Aretz S., Sampson J.R. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 2009, 137:489-494. 494 e481; quiz 725-486.
196. Aspinwall R., Rothwell D.G., Roldan-Arjona T., Anselmino C., Ward C.J., Cheadle J.P., Sampson J.R., Lindahl T., Harris P.C., Hickson I.D. Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III. Proc. Natl. Acad. Sci. USA 1997, 94:109-114.
197. Hilbert T.P., Chaung W., Boorstein R.J., Cunningham R.P., Teebor G.W. Cloning and expression of the cDNA encoding the human homologue of the DNA repair enzyme, Escherichia coli endonuclease III. J. Biol. Chem. 1997, 272:6733-6740.
198. Ikeda S., Biswas T., Roy R., Izumi T., Boldogh I., Kurosky A., Sarker A.H., Seki S., Mitra S. Purification and characterization of human NTH1, a homolog of Escherichia coli endonuclease III. Direct identification of Lys-212 as the active nucleophilic residue. J. Biol. Chem. 1998, 273:21585-21593.
199. Eide L., Luna L., Gustad E.C., Henderson P.T., Essigmann J.M., Demple B., Seeberg E. Human endonuclease III acts preferentially on DNA damage opposite guanine residues in DNA. Biochemistry 2001, 40:6653-6659.
200. Hazra T.K., Das A., Das S., Choudhury S., Kow Y.W., Roy R. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst.) 2007, 6:470-480.
201. Thayer M.M., Ahern H., Xing D., Cunningham R.P., Tainer J.A. Novel DNA binding motifs in the DNA repair enzyme endonuclease III crystal structure. EMBO J. 1995, 14:4108-4120.
202. Hazra T.K., Izumi T., Boldogh I., Imhoff B., Kow Y.W., Jaruga P., Dizdaroglu M., Mitra S. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc. Natl. Acad. Sci. USA 2002, 99:3523-3528.
203. Dou H., Theriot C.A., Das A., Hegde M.L., Matsumoto Y., Boldogh I., Hazra T.K., Bhakat K.K., Mitra S. Interaction of the human DNA glycosylase NEIL1 with proliferating cell nuclear antigen. The potential for replication-associated repair of oxidized bases in mammalian genomes. J. Biol. Chem. 2008, 283:3130-3140.
204. Hegde M.L., Theriot C.A., Das A., Hegde P.M., Guo Z., Gary R.K., Hazra T.K., Shen B., Mitra S. Physical and functional interaction between human oxidized base-specific DNA glycosylase NEIL1 and flap endonuclease 1. J. Biol. Chem. 2008, 283:27028-27037.
205. Theriot C.A., Hegde M.L., Hazra T.K., Mitra S. RPA physically interacts with the human DNA glycosylase NEIL1 to regulate excision of oxidative DNA base damage in primer-template structures. DNA Repair (Amst.) 2010, 9:643-652.
206. Bandaru V., Sunkara S., Wallace S.S., Bond J.P. A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair (Amst.) 2002, 1:517-529.
207. Hazra T.K., Kow Y.W., Hatahet Z., Imhoff B., Boldogh I., Mokkapati S.K., Mitra S., Izumi T. Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J. Biol. Chem. 2002, 277:30417-30420.
208. Morland I., Rolseth V., Luna L., Rognes T., Bjoras M., Seeberg E. Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res. 2002, 30:4926-4936.
209. Takao M., Kanno S., Kobayashi K., Zhang Q.M., Yonei S., van der Horst G.T., Yasui A. A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue. J. Biol. Chem. 2002, 277:42205-42213.
210. Jaruga P., Birincioglu M., Rosenquist T.A., Dizdaroglu M. Mouse NEIL1 protein is specific for excision of 2,6-diamino-4-hydroxy-5-formamidopyrimidine and 4,6-diamino-5-formamidopyrimidine from oxidatively damaged DNA. Biochemistry 2004, 43:15909-15914.
211. Katafuchi A., Nakano T., Masaoka A., Terato H., Iwai S., Hanaoka F., Ide H. Differential specificity of human and Escherichia coli endonuclease III and VIII homologues for oxidative base lesions. J. Biol. Chem. 2004, 279:14464-14471.
212. McTigue M.M., Rieger R.A., Rosenquist T.A., Iden C.R., De Los Santos C.R. Stereoselective excision of thymine glycol lesions by mammalian cell extracts. DNA Repair (Amst.) 2004, 3:313-322.
213. Miller H., Fernandes A.S., Zaika E., McTigue M.M., Torres M.C., Wente M., Iden C.R., Grollman A.P. Stereoselective excision of thymine glycol from oxidatively damaged DNA. Nucleic Acids Res. 2004, 32:338-345.
214. Zhang Q.M., Yonekura S., Takao M., Yasui A., Sugiyama H., Yonei S. DNA glycosylase activities for thymine residues oxidized in the methyl group are functions of the hNEIL1 and hNTH1 enzymes in human cells. DNA Repair (Amst.) 2005, 4:71-79.
215. Ocampo-Hafalla M.T., Altamirano A., Basu A.K., Chan M.K., Ocampo J.E., Cummings A., Boorstein R.J., Cunningham R.P., Teebor G.W. Repair of thymine glycol by hNth1 and hNeil1 is modulated by base pairing and cis-trans epimerization. DNA Repair (Amst.) 2006, 5:444-454.
216. Grin I.R., Dianov G.L., Zharkov D.O. The role of mammalian NEIL1 protein in the repair of 8-oxo-7,8-dihydroadenine in DNA. FEBS Lett. 2010, 584:1553-1557.
217. Krishnamurthy N., Zhao X., Burrows C.J., David S.S. Superior removal of hydantoin lesions relative to other oxidized bases by the human DNA glycosylase hNEIL1. Biochemistry 2008, 47:7137-7146.
218. Zhao X., Krishnamurthy N., Burrows C.J., David S.S. Mutation versus repair: NEIL1 removal of hydantoin lesions in single-stranded, bulge, bubble, and duplex DNA contexts. Biochemistry 2010, 49:1658-1666.
219. Doublie S., Bandaru V., Bond J.P., Wallace S.S. The crystal structure of human endonuclease VIII-like 1 (NEIL1) reveals a zincless finger motif required for glycosylase activity. Proc. Natl. Acad. Sci. USA 2004, 101:10284-10289.
220. Dou H., Mitra S., Hazra T.K. Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. J. Biol. Chem. 2003, 278:49679-49684.
221. Hailer M.K., Slade P.G., Martin B.D., Rosenquist T.A., Sugden K.D. Recognition of the oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the mammalian base excision repair glycosylases NEIL1 and NEIL2. DNA Repair (Amst.) 2005, 4:41-50.
222. Banerjee D., Mandal S.M., Das A., Hegde M.L., Das S., Bhakat K.K., Boldogh I., Sarkar P.S., Mitra S., Hazra T.K. Preferential repair of oxidized base damage in the transcribed genes of mammalian cells. J. Biol. Chem. 2011, 286:6006-6016.
223. Liu M., Bandaru V., Bond J.P., Jaruga P., Zhao X., Christov P.P., Burrows C.J., Rizzo C.J., Dizdaroglu M., Wallace S.S. The mouse ortholog of NEIL3 is a functional DNA glycosylase in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2010, 107:4925-4930.
224. Torisu K., Tsuchimoto D., Ohnishi Y., Nakabeppu Y. Hematopoietic tissue-specific expression of mouse Neil3 for endonuclease VIII-like protein. J. Biochem. 2005, 138:763-772.
225. Takao M., Oohata Y., Kitadokoro K., Kobayashi K., Iwai S., Yasui A., Yonei S., Zhang Q.M. Human Nei-like protein NEIL3 has AP lyase activity specific for single-stranded DNA and confers oxidative stress resistance in Escherichia coli mutant. Genes. Cells 2009, 14:261-270.
226. Ocampo M.T., Chaung W., Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J., Cunningham R.P., Teebor G.W. Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity. Mol. Cell Biol. 2002, 22:6111-6121.
227. Takao M., Kanno S., Shiromoto T., Hasegawa R., Ide H., Ikeda S., Sarker A.H., Seki S., Xing J.Z., Le X.C., Weinfeld M., Kobayashi K., Miyazaki J., Muijtjens M., Hoeijmakers J.H., van der Horst G., Yasui A. Novel nuclear and mitochondrial glycosylases revealed by disruption of the mouse Nth1 gene encoding an endonuclease III homolog for repair of thymine glycols. EMBO J. 2002, 21:3486-3493.
228. Vartanian V., Lowell B., Minko I.G., Wood T.G., Ceci J.D., George S., Ballinger S.W., Corless C.L., McCullough A.K., Lloyd R.S. The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. Proc. Natl. Acad. Sci. USA 2006, 103:1864-1869.
229. Hu J., de Souza-Pinto N.C., Haraguchi K., Hogue B.A., Jaruga P., Greenberg M.M., Dizdaroglu M., Bohr V.A. Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes. J. Biol. Chem. 2005, 280:40544-40551.
230. Sampath H., Batra A.K., Vartanian V., Carmical J.R., Prusak D., King I.B., Lowell B., Earley L.F., Wood T.G., Marks D.L., McCullough A.K., Stephen R. Variable penetrance of metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E724-734.
231. Chan M.K., Ocampo-Hafalla M.T., Vartanian V., Jaruga P., Kirkali G., Koenig K.L., Brown S., Lloyd R.S., Dizdaroglu M., Teebor G.W. Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA. DNA Repair (Amst.) 2009, 8:786-794.
232. Roy L.M., Jaruga P., Wood T.G., McCullough A.K., Dizdaroglu M., Lloyd R.S. Human polymorphic variants of the NEIL1 DNA glycosylase. J. Biol. Chem. 2007, 282:15790-15798.
233. Shinmura K., Tao H., Goto M., Igarashi H., Taniguchi T., Maekawa M., Takezaki T., Sugimura H. Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer. Carcinogenesis 2004, 25:2311-2317.
234. Goto M., Shinmura K., Tao H., Tsugane S., Sugimura H. Three novel NEIL1 promoter polymorphisms in gastric cancer patients. World J. Gastrointest. Oncol. 2010, 2:117-120.
235. Demple B., Sung J.S. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst.) 2005, 4:1442-1449.
236. Xanthoudakis S., Miao G., Wang F., Pan Y.C., Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 1992, 11:3323-3335.
237. Evans A.R., Limp-Foster M., Kelley M.R. Going APE over ref-1. Mutat. Res. 2000, 461:83-108.
238. Demple B., Herman T., Chen D.S. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc. Natl. Acad. Sci. USA 1991, 88:11450-11454.
239. Robson C.N., Hickson I.D. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res. 1991, 19:5519-5523.
240. Seki S., Hatsushika M., Watanabe S., Akiyama K., Nagao K., Tsutsui K. cDNA cloning, sequencing, expression and possible domain structure of human APEX nuclease homologous to Escherichia coli exonuclease III. Biochim. Biophys. Acta 1992, 1131:287-299.
241. Gorman M.A., Morera S., Rothwell D.G., de La Fortelle E., Mol C.D., Tainer J.A., Hickson I.D., Freemont P.S. The crystal structure of the human DNA repair endonuclease HAP1 suggests the recognition of extra-helical deoxyribose at DNA abasic sites. EMBO J. 1997, 16:6548-6558.
242. Hadi M.Z., Wilson D.M. Second human protein with homology to the Escherichia coli abasic endonuclease exonuclease III. Environ. Mol. Mutagen 2000, 36:312-324.
243. Burkovics P., Szukacsov V., Unk I., Haracska L. Human Ape2 protein has a 3'-5' exonuclease activity that acts preferentially on mismatched base pairs. Nucleic Acids Res. 2006, 34:2508-2515.
244. Burkovics P., Hajdu I., Szukacsov V., Unk I., Haracska L. Role of PCNA-dependent stimulation of 3'-phosphodiesterase and 3'-5' exonuclease activities of human Ape2 in repair of oxidative DNA damage. Nucleic Acids Res. 2009, 37:4247-4255.
245. Hadi M.Z., Ginalski K., Nguyen L.H., Wilson D.M. Determinants in nuclease specificity of Ape1 and Ape2, human homologues of Escherichia coli exonuclease III. J. Mol. Biol. 2002, 316:853-866.
246. Guikema J.E., Gerstein R.M., Linehan E.K., Cloherty E.K., Evan-Browning E., Tsuchimoto D., Nakabeppu Y., Schrader C.E. Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge. J. Immunol. 2011, 186:1943-1950.
247. Xanthoudakis S., Curran T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv. Exp. Med. Biol. 1996, 387:69-75.
248. Ludwig D.L., MacInnes M.A., Takiguchi Y., Purtymun P.E., Henrie M., Flannery M., Meneses J., Pedersen R.A., Chen D.J. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 1998, 409:17-29.
249. Meira L.B., Devaraj S., Kisby G.E., Burns D.K., Daniel R.L., Hammer R.E., Grundy S., Jialal I., Friedberg E.C. Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res. 2001, 61:5552-5557.
250. Izumi T., Brown D.B., Naidu C.V., Bhakat K.K., Macinnes M.A., Saito H., Chen D.J., Mitra S. Two essential but distinct functions of the mammalian abasic endonuclease. Proc. Natl. Acad. Sci. USA 2005, 102:5739-5743.
251. Fung H., Demple B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol. Cell 2005, 17:463-470.
252. Huamani J., McMahan C.A., Herbert D.C., Reddick R., McCarrey J.R., MacInnes M.I., Chen D.J., Walter C.A. Spontaneous mutagenesis is enhanced in Apex heterozygous mice. Mol. Cell Biol. 2004, 24:8145-8153.
253. Raffoul J.J., Cabelof D.C., Nakamura J., Meira L.B., Friedberg E.C., Heydari A.R. Apurinic/apyrimidinic endonuclease (APE/REF-1) haploinsufficient mice display tissue-specific differences in DNA polymerase beta-dependent base excision repair. J. Biol. Chem. 2004, 279:18425-18433.
254. Huang M., Dinney C.P., Lin X., Lin J., Grossman H.B., Wu X. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 2007, 16:84-91.
255. Wang M., Qin C., Zhu J., Yuan L., Fu G., Zhang Z., Yin C. Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol. 2010, 29:303-311.
256. Agachan B., Kucukhuseyin O., Aksoy P., Turna A., Yaylim I., Gormus U., Ergen A., Zeybek U., Dalan B., Isbir T. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking. Anticancer Res. 2009, 29:2417-2420.
257. Kiyohara C., Takayama K., Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006, 54:267-283.
258. Kuasne H., Rodrigues I.S., Losi-Guembarovski R., Reis M.B., Fuganti P.E., Gregorio E.P., Libos Junior F., Matsuda H.M., Rodrigues M.A., Kishima M.O., Colus I.M. Base excision repair genes XRCC1 and APEX1 and the risk for prostate cancer. Mol. Biol. Rep. 2011, 38:1585-1591.
259. Canbay E., Agachan B., Gulluoglu M., Isbir T., Balik E., Yamaner S., Bulut T., Cacina C., Eraltan I.Y., Yilmaz A., Bugra D. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res. 2010, 30:1359-1364.
260. Hu J.J., Smith T.R., Miller M.S., Lohman K., Case L.D. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ. Mol. Mutagen 2002, 39:208-215.
261. Zhang Y., Newcomb P.A., Egan K.M., Titus-Ernstoff L., Chanock S., Welch R., Brinton L.A., Lissowska J., Bardin-Mikolajczak A., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15:353-358.
262. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C.S., Bowman R., Meyer K.B., Haiman C.A., Kolonel L.K., Henderson B.E., Le Marchand L., Brennan P., Sangrajrang S., Gaborieau V., Odefrey F., Shen C.Y., Wu P.E., Wang H.C., Eccles D., Evans D.G., Peto J., Fletcher O., Johnson N., Seal S., Stratton M.R., Rahman N., Chenevix-Trench G., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Garcia-Closas M., Brinton L., Chanock S., Lissowska J., Peplonska B., Nevanlinna H., Fagerholm R., Eerola H., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Hunter D.J., Hankinson S.E., Cox D.G., Hall P., Wedren S., Liu J., Low Y.L., Bogdanova N., Schurmann P., Dork T., Tollenaar R.A., Jacobi C.E., Devilee P., Klijn J.G., Sigurdson A.J., Doody M.M., Alexander B.H., Zhang J., Cox A., Brock I.W., MacPherson G., Reed M.W., Couch F.J., Goode E.L., Olson J.E., Meijers-Heijboer H., van den Ouweland A., Uitterlinden A., Rivadeneira F., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Hopper J.L., McCredie M., Southey M., Giles G.G., Schroen C., Justenhoven C., Brauch H., Hamann U., Ko Y.D., Spurdle A.B., Beesley J., Chen X., Mannermaa A., Kosma V.M., Kataja V., Hartikainen J., Day N.E., Cox D.R., Ponder B.A. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
263. Thomas G., Jacobs K.B., Kraft P., Yeager M., Wacholder S., Cox D.G., Hankinson S.E., Hutchinson A., Wang Z., Yu K., Chatterjee N., Garcia-Closas M., Gonzalez-Bosquet J., Prokunina-Olsson L., Orr N., Willett W.C., Colditz G.A., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Diver R., Prentice R., Jackson R., Kooperberg C., Chlebowski R., Lissowska J., Peplonska B., Brinton L.A., Sigurdson A., Doody M., Bhatti P., Alexander B.H., Buring J., Lee I.M., Vatten L.J., Hveem K., Kumle M., Hayes R.B., Tucker M., Gerhard D.S., Fraumeni J.F., Hoover R.N., Chanock S.J., Hunter D.J. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 2009, 41:579-584.
264. Turnbull C., Ahmed S., Morrison J., Pernet D., Renwick A., Maranian M., Seal S., Ghoussaini M., Hines S., Healey C.S., Hughes D., Warren-Perry M., Tapper W., Eccles D., Evans D.G., Hooning M., Schutte M., van den Ouweland A., Houlston R., Ross G., Langford C., Pharoah P.D., Stratton M.R., Dunning A.M., Rahman N., Easton D.F. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 2010, 42:504-507.
265. Gu D., Wang M., Zhang Z., Chen J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Mutagenesis 2009, 24:507-512.
266. Hadi M.Z., Coleman M.A., Fidelis K., Mohrenweiser H.W., Wilson D.M. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res. 2000, 28:3871-3879.
267. Daviet S., Couve-Privat S., Gros L., Shinozuka K., Ide H., Saparbaev M., Ishchenko A.A. Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway. DNA Repair (Amst.) 2007, 6:8-18.
268. Pieretti M., Khattar N.H., Smith S.A. Common polymorphisms and somatic mutations in human base excision repair genes in ovarian and endometrial cancers. Mutat. Res. 2001, 432:53-59.
269. Kunkel T.A. The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations. J. Biol. Chem. 1985, 260:5787-5796.
270. Prasad R., Beard W.A., Chyan J.Y., Maciejewski M.W., Mullen G.P., Wilson S.H. Functional analysis of the amino-terminal 8-kDa domain of DNA polymerase beta as revealed by site-directed mutagenesis. DNA binding and 5'-deoxyribose phosphate lyase activities. J. Biol. Chem. 1998, 273:11121-11126.
271. Sobol R.W., Prasad R., Evenski A., Baker A., Yang X.P., Horton J.K., Wilson S.H. The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity. Nature 2000, 405:807-810.
272. Pelletier H., Sawaya M.R., Kumar A., Wilson S.H., Kraut J. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science 1994, 264:1891-1903.
273. Beard W.A., Prasad R., Wilson S.H. Activities and mechanism of DNA polymerase beta. Methods Enzymol. 2006, 408:91-107.
274. Batra V.K., Beard W.A., Hou E.W., Pedersen L.C., Prasad R., Wilson S.H. Mutagenic conformation of 8-oxo-7,8-dihydro-2'-dGTP in the confines of a DNA polymerase active site. Nat. Struct. Mol. Biol. 2010, 17:889-890.
275. Cavanaugh N.A., Beard W.A., Wilson S.H. DNA polymerase beta ribonucleotide discrimination: insertion, misinsertion, extension, and coding. J. Biol. Chem. 2010, 285:24457-24465.
276. Cavanaugh N.A., Beard W.A., Batra V.K., Perera L., Pedersen L.G., Wilson S.H. Molecular insights into DNA polymerase deterrents for ribonucleotide insertion. J. Biol. Chem. 2011, 286:31650-31660.
277. Batra V.K., Beard W.A., Shock D.D., Pedersen L.C., Wilson S.H. Structures of DNA polymerase beta with active-site mismatches suggest a transient abasic site intermediate during misincorporation. Mol. Cell 2008, 30:315-324.
278. Beard W.A., Shock D.D., Batra V.K., Pedersen L.C., Wilson S.H. DNA polymerase beta substrate specificity: side chain modulation of the "A-rule" J. Biol. Chem. 2009, 284:31680-31689.
279. Yamtich J., Starcevic D., Lauper J., Smith E., Shi I., Rangarajan S., Jaeger J., Sweasy J.B. Hinge residue I174 is critical for proper dNTP selection by DNA polymerase beta. Biochemistry 2010, 49:2326-2334.
280. Lin G.C., Jaeger J., Eckert K.A., Sweasy J.B. Loop II of DNA polymerase beta is important for discrimination during substrate binding. DNA Repair (Amst.) 2009, 8:182-189.
281. Yamtich J., Speed W.C., Straka E., Kidd J.R., Sweasy J.B., Kidd K.K. Population-specific variation in haplotype composition and heterozygosity at the POLB locus. DNA Repair (Amst.) 2009, 8:579-584.
282. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994, 265:103-106.
283. Sugo N., Aratani Y., Nagashima Y., Kubota Y., Koyama H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO J. 2000, 19:1397-1404.
284. Cabelof D.C., Guo Z., Raffoul J.J., Sobol R.W., Wilson S.H., Richardson A., Heydari A.R. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. Cancer Res. 2003, 63:5799-5807.
285. Guo Z., Zheng L., Dai H., Zhou M., Xu H., Shen B. Human DNA polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity. Nucleic Acids Res. 2009, 37:3431-3441.
286. Matakidou A., el Galta R., Webb E.L., Rudd M.F., Bridle H., Eisen T., Houlston R.S. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum. Mol. Genet. 2007, 16:2333-2340.
287. Starcevic D., Dalal S., Sweasy J.B. Is there a link between DNA polymerase beta and cancer?. Cell Cycle 2004, 3:998-1001.
288. Lang T., Maitra M., Starcevic D., Li S.X., Sweasy J.B. A DNA polymerase beta mutant from colon cancer cells induces mutations. Proc. Natl. Acad. Sci. USA 2004, 101:6074-6079.
289. Dalal S., Hile S., Eckert K.A., Sun K.W., Starcevic D., Sweasy J.B. Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator. Biochemistry 2005, 44:15664-15673.
290. Lang T., Dalal S., Chikova A., DiMaio D., Sweasy J.B. The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol. Cell Biol. 2007, 27:5587-5596.
291. Dalal S., Chikova A., Jaeger J., Sweasy J.B. The Leu22Pro tumor-associated variant of DNA polymerase beta is dRP lyase deficient. Nucleic Acids Res. 2008, 36:411-422.
292. Sweasy J.B., Lang T., Starcevic D., Sun K.W., Lai C.C., Dimaio D., Dalal S. Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation. Proc. Natl. Acad. Sci. USA 2005, 102:14350-14355.
293. Srivastava D.K., Husain I., Arteaga C.L., Wilson S.H. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis 1999, 20:1049-1054.
294. Bergoglio V., Pillaire M.J., Lacroix-Triki M., Raynaud-Messina B., Canitrot Y., Bieth A., Gares M., Wright M., Delsol G., Loeb L.A., Cazaux C., Hoffmann J.S. Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res. 2002, 62:3511-3514.
295. Canitrot Y., Capp J.P., Puget N., Bieth A., Lopez B., Hoffmann J.S., Cazaux C. DNA polymerase beta overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells. Nucleic Acids Res. 2004, 32:5104-5112.
296. Yoshizawa K., Jelezcova E., Brown A.R., Foley J.F., Nyska A., Cui X., Hofseth L.J., Maronpot R.M., Wilson S.H., Sepulveda A.R., Sobol R.W. Gastrointestinal hyperplasia with altered expression of DNA polymerase beta. PLoS One 2009, 4:e6493.
297. Glassner B.J., Rasmussen L.J., Najarian M.T., Posnick L.M., Samson L.D. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc. Natl. Acad. Sci. USA 1998, 95:9997-10002.
298. Dong Z., Tomkinson A.E. ATM mediates oxidative stress-induced dephosphorylation of DNA ligase IIIalpha. Nucleic Acids Res. 2006, 34. 5721-5279.
299. Odell I.D., Barbour J.E., Murphy D.L., Della Maria J.A., Sweasy J.B., Tomkinson A.E., Wallace S.S., Pederson D.S. Nucleosome disruption by DNA ligase III-XRCC1 promotes efficient base excision repair. Mol. Cell Biol. 2011.
300. Puebla-Osorio N., Lacey D.B., Alt F.W., Zhu C. Early embryonic lethality due to targeted inactivation of DNA ligase III. Mol. Cell Biol. 2006, 26:3935-3941.
301. Simsek D., Furda A., Gao Y., Artus J., Brunet E., Hadjantonakis A.K., Van Houten B., Shuman S., McKinnon P.J., Jasin M. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 2011, 471:245-248.
302. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst.) 2003, 2:955-969.
303. Simsek D., Brunet E., Wong S.Y., Katyal S., Gao Y., McKinnon P.J., Lou J., Zhang L., Li J., Rebar E.J., Gregory P.D., Holmes M.C., Jasin M. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet. 2011, 7:e1002080.
304. Della-Maria J., Zhou Y., Tsai M.S., Kuhnlein J., Carney J.P., Paull T.T., Tomkinson A.E. Human Mre11/Human Rad50/Nbs1 and DNA ligase III{alpha}/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway. J. Biol. Chem. 2011, 286:33845-33853.
305. Breslin C., Caldecott K.W. DNA 3'-phosphatase activity is critical for rapid global rates of single-strand break repair following oxidative stress. Mol. Cell Biol. 2009, 29:4653-4662.
306. Akbari M., Solvang-Garten K., Hanssen-Bauer A., Lieske N.V., Pettersen H.S., Pettersen G.K., Wilson D.M., Krokan H.E., Otterlei M. Direct interaction between XRCC1 and UNG2 facilitates rapid repair of uracil in DNA by XRCC1 complexes. DNA Repair (Amst.) 2010, 9:785-795.
307. Levy N., Oehlmann M., Delalande F., Nasheuer H.P., Van Dorsselaer A., Schreiber V., de Murcia G., Menissier-de Murcia J., Maiorano D., Bresson A. XRCC1 interacts with the p58 subunit of DNA Pol alpha-primase and may coordinate DNA repair and replication during S phase. Nucleic Acids Res. 2009, 37:3177-3188.
308. Vidal A.E., Boiteux S., Hickson I.D., Radicella J.P. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001, 20:6530-6539.
309. Yamamori T., DeRicco J., Naqvi A., Hoffman T.A., Mattagajasingh I., Kasuno K., Jung S.B., Kim C.S., Irani K. SIRT1 deacetylates APE1 and regulates cellular base excision repair. Nucleic Acids Res. 2010, 38:832-845.
310. Tebbs R.S., Flannery M.L., Meneses J.J., Hartmann A., Tucker J.D., Thompson L.H., Cleaver J.E., Pedersen R.A. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev. Biol. 1999, 208:513-529.
311. McNeill D.R., Lin P.C., Miller M.G., Pistell P.J., de Souza-Pinto N.C., Fishbein K.W., Spencer R.G., Liu Y., Pettan-Brewer C., Ladiges W.C., Wilson D.M. XRCC1 haploinsufficiency in mice has little effect on aging, but adversely modifies exposure-dependent susceptibility. Nucleic Acids Res. 2011.
312. Thompson L.H., Brookman K.W., Dillehay L.E., Carrano A.V., Mazrimas J.A., Mooney C.L., Minkler J.L. A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange. Mutat. Res. 1982, 95:427-440.
313. Thompson L.H., Brookman K.W., Jones N.J., Allen S.A., Carrano A.V. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol. Cell Biol. 1990, 10:6160-6171.
314. Berquist B.R., Singh D.K., Fan J., Kim D., Gillenwater E., Kulkarni A., Bohr V.A., Ackerman E.J., Tomkinson A.E., Wilson D.M. Functional capacity of XRCC1 protein variants identified in DNA repair-deficient Chinese hamster ovary cell lines and the human population. Nucleic Acids Res. 2010, 38:5023-5035.
315. Ginsberg G., Angle K., Guyton K., Sonawane B. Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat. Res. 2011, 727:1-15.
316. Roszak A., Lianeri M., Jagodzinski P.P. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma. Int. J. Biol. Markers 2011.
317. Barbisan G., Perez L.O., Difranza L., Fernandez C.J., Ciancio N.E., Golijow C.D. XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women. Eur. J. Gynaecol. Oncol. 2011, 32:274-279.
318. Geng J., Zhang Q., Zhu C., Wang J., Chen L. XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis. Urology 2009, 74:648-653.
319. Wei B., Zhou Y., Xu Z., Ruan J., Zhu M., Jin K., Zhou D., Hu Q., Wang Q., Wang Z., Yan Z. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic. Dis. 2011, 14:225-231.
320. Roberts M.R., Shields P.G., Ambrosone C.B., Nie J., Marian C., Krishnan S.S., Goerlitz D.S., Modali R., Seddon M., Lehman T., Amend K.L., Trevisan M., Edge S.B., Freudenheim J.L. Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 2011, 32:1223-1230.
321. Ryu R.A., Tae K., Min H.J., Jeong J.H., Cho S.H., Lee S.H., Ahn Y.H. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J. Korean Med. Sci. 2011, 26:991-995.
322. Chiang F.Y., Wu C.W., Hsiao P.J., Kuo W.R., Lee K.W., Lin J.C., Liao Y.C., Juo S.H. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin. Cancer Res. 2008, 14:5919-5924.
323. Xue H., Ni P., Lin B., Xu H., Huang G. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and meta-analysis. Am. J. Epidemiol. 2011, 173:363-375.
324. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., Kumar R., Hanova M., Pardini B., Slyskova J., Musak L., De Palma G., Soucek P., Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007, 28:657-664.
325. Halasova E., Matakova T., Musak L., Polakova V., Letkova L., Dobrota D., Vodicka P. Evaluating chromosomal damage in workers exposed to hexavalent chromium and the modulating role of polymorphisms of DNA repair genes. Int. Arch. Occup. Environ. Health 2011.
326. Chandirasekar R., Suresh K., Jayakumar R., Venkatesan R., Lakshman Kumar B., Sasikala K. XRCC1 gene variants and possible links with chromosome aberrations and micronucleus in active and passive smokers. Environ. Toxicol. Pharmacol. 2011, 32:185-192.
327. Li D., Zhou Q., Liu Y., Yang Y., Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med. Oncol. 2011.
328. Berger S.H., Pittman D.L., Wyatt M.D. Uracil in DNA: consequences for carcinogenesis and chemotherapy. Biochem. Pharmacol. 2008, 76:697-706.
329. Li S.X., Sjolund A., Harris L., Sweasy J.B. DNA repair and personalized breast cancer therapy. Environ. Mol. Mutagen. 2010, 51:897-908.
330. Tell G., Wilson D.M. Targeting DNA repair proteins for cancer treatment. Cell Mol. Life Sci. 2010, 67:3569-3572.
331. Tentori L., Orlando L., Lacal P.M., Benincasa E., Faraoni I., Bonmassar E., D'Atri S., Graziani G. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide. Mol. Pharmacol. 1997, 52:249-258.
332. Trivedi R.N., Wang X.H., Jelezcova E., Goellner E.M., Tang J.B., Sobol R.W. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide. Mol. Pharmacol. 2008, 74:505-516.
333. Tang J.B., Svilar D., Trivedi R.N., Wang X.H., Goellner E.M., Moore B., Hamilton R.L., Banze L.A., Brown A.R., Sobol R.W. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. Neuro Oncol. 2011, 13:471-486.
334. Goellner E.M., Grimme B., Brown A.R., Lin Y.C., Wang X.H., Sugrue K.F., Mitchell L., Trivedi R.N., Tang J.B., Sobol R.W. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res. 2011, 71:2308-2317.
335. Mohammed M.Z., Vyjayanti V.N., Laughton C.A., Dekker L.V., Fischer P.M., Wilson D.M., Abbotts R., Shah S., Patel P.M., Hickson I.D., Madhusudan S. Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines. Br. J. Cancer. 2011, 104:653-663.
336. Simeonov A., Kulkarni A., Dorjsuren D., Jadhav A., Shen M., McNeill D.R., Austin C.P., Wilson D.M. Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1. PLoS One 2009, 4:e5740.
337. Tell G., Fantini D., Quadrifoglio F. Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment. Cell Mol. Life Sci. 2010, 67:3589-3608.
338. Wilson D.M., Simeonov A. Small molecule inhibitors of DNA repair nuclease activities of APE1. Cell Mol. Life Sci. 2010, 67:3621-3631.
339. Stachelek G.C., Dalal S., Donigan K.A., Campisi Hegan D., Sweasy J.B., Glazer P.M. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res. 2010, 70:409-417.
340. Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol. Oncol. 2011, 5:387-393.
341. Horton J.K., Wilson S.H. Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency. DNA Repair (Amst.) 2007, 6:530-543.
342. Jelezcova E., Trivedi R.N., Wang X.H., Tang J.B., Brown A.R., Goellner E.M., Schamus S., Fornsaglio J.L., Sobol R.W. Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage. Mutat. Res. 2010, 686:57-67.
343. Sucato C.A., Upton T.G., Kashemirov B.A., Osuna J., Oertell K., Beard W.A., Wilson S.H., Florian J., Warshel A., McKenna C.E., Goodman M.F. DNA polymerase beta fidelity: halomethylene-modified leaving groups in pre-steady-state kinetic analysis reveal differences at the chemical transition state. Biochemistry 2008, 47:870-879.
344. McKenna C.E., Kashemirov B.A., Peterson L.W., Goodman M.F. Modifications to the dNTP triphosphate moiety: from mechanistic probes for DNA polymerases to antiviral and anti-cancer drug design. Biochim. Biophys. Acta 2010, 1804:1223-1230.
345. Chen X., Zhong S., Zhu X., Dziegielewska B., Ellenberger T., Wilson G.M., MacKerell A.D., Tomkinson A.E. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res. 2008, 68:3169-3177.
346. Zhong S., Chen X., Zhu X., Dziegielewska B., Bachman K.E., Ellenberger T., Ballin J.D., Wilson G.M., Tomkinson A.E., MacKerell A.D. Identification and validation of human DNA ligase inhibitors using computer-aided drug design. J. Med. Chem. 2008, 51:4553-4562.